1. Enzyme-Activatable Near-Infrared Hemicyanines as Modular Scaffolds for in vivo Photodynamic Therapy.
- Author
-
Cheng Z, Benson S, Mendive-Tapia L, Nestoros E, Lochenie C, Seah D, Chang KY, Feng Y, and Vendrell M
- Subjects
- Humans, Cell Line, Tumor, Animals, Carbocyanines chemistry, Glioblastoma drug therapy, Glioblastoma pathology, Glioblastoma metabolism, Antineoplastic Agents chemistry, Antineoplastic Agents pharmacology, Mice, Photochemotherapy, Photosensitizing Agents chemistry, Photosensitizing Agents pharmacology, Infrared Rays
- Abstract
Photodynamic therapy is an anti-cancer treatment that requires illumination of photosensitizers to induce local cell death. Current near-infrared organic photosensitizers are built from large and non-modular structures that cannot be tuned to improve safety and minimize off-target toxicity. This work describes a novel chemical platform to generate enzyme-activatable near-infrared photosensitizers. We optimized the Se-bridged hemicyanine scaffold to include caging groups and biocompatible moieties, and generated cathepsin-triggered photosensitizers for effective ablation of human glioblastoma cells. Furthermore, we demonstrated that enzyme-activatable Se-bridged hemicyanines are effective photosensitizers for the safe ablation of microtumors in vivo, creating new avenues in the chemical design of targeted anti-cancer photodynamic therapy agents., (© 2024 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH.)
- Published
- 2024
- Full Text
- View/download PDF